Assisted Reproductive Technologies
Assisted Reproductive Technologies are all treatments which include the handling of eggs and sperm and/or embryos. Some examples of ART are in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), pronuclear stage tubal transfer (PROST), tubal embryo transfer (TET), and zygote intrafallopian transfer (ZIFT).
What's New at ASRM
- ASRM COVID-19 Task Force Releases Update #9 to Recommendations
- Fertility and Sterility On Air - Unplugged: July 2022
- State Insurance Mandates Have A Positive Impact On Infertility Treatment Success
- UPDATE No. 18 - COVID-19 Vaccination, Booster Shots and Reproductive Health Care
- SART Fertility Experts - Egg Donor and Recipient
- ASRM COVID-19 Task Force Releases Update #10 to Recommendations
- ASRM Issues New Guidance on Fertility Care During COVID-19 Pandemic: Calls for Suspension of Most Treatments
- Infertility Treatments Remained Strong With Good Outcomes In Spite Of Covid-19, According To Three Studies Presented At The ASRM 2021 Scientific Sessions
- The Supreme Court Overturns Right to Abortion, Raising Questions and Uncertainties for ART Patients and Providers
- Fertility and Sterility On Air – TOC: June 2022
- Fertility and Sterility On Air At ASRM 2021: Part 1 - The Missions of ASRM
- Fertility and Sterility On Air - Unplugged: June 2022
- Most patients resumed IVF treatment during the COVID-19 pandemic shut-down immediately when able
- More Than 73 Thousand Babies Born from Assisted Reproductive Technology Cycles Done in 2020
- ASRM Today - Update #9 from the ASRM COVID-19 Task Force with Christos Coutifaris
- FAQs for Patients Related to COVID-19
- Fertility and Sterility On Air - TOC: April 2022
- Fertility and Sterility On Air– TOC: August 2022
- Update #1 Released to the ASRM Patient Management and Clinical Recommendations During The Coronavirus (COVID-19) Pandemic
- Fertility and Sterility On Air– TOC: July 2022
Resources
- Infertility treatments, including IVF and similar procedures, account for approx 0.07 percent of U.S. health care costs
- One Million IVF Babies
- What is In Vitro Fertilization?
- Challenges of parenting multiples 养育多胞胎的挑战
- What is ICSI 什么是卵胞浆内单精子注射
- Derechos y responsabilidades en relación con la fertilidad (Fertility rights and responsibilities)
- Complicaciones de la gestacion multiple (Complications of multiple pregnancy)
- Gestacion multiple y reduccion embrionaria (Multifetal pregnancy reduction)
- Los farmacos para la fertilidad y el risego de partos multiples (Fertility medications and the risk of multiple birth)
- Tratamiento de la pérdida recurrente de embarazos (Treatment of recurrent pregnancy loss)
- The Goal Of Infertility Treatment
- Multiple Pregnancy Is Risky
- Is In Vitro Fertilization Expensive?
- Acupuncture and infertility treatment 针灸与不孕不育的治疗
- IVF: What are the risks? 体外受精:风险有哪些?
- ¿Qué debo saber sobre el virus Zika y tratar de tener un bebé? (What do I need to know about Zika virus and having a baby?)
- Suplementos de progesterona durante los ciclos de fertilización in vitro (FIV) (Progesterone supplementation during IVF cycles)
- Assisted hatching 辅助孵化
- Smoking and infertility 吸烟和不孕不育
- Why would I choose to have elective single-embryo transfer? 我为什么要接受选择性单胚胎移植
- ¿Qué es la maduración in vitro (MIV)? (What is IVM?)
- Eclosión asistida (Assisted hatching)
- Cuidado reproductivo fronterizo (Cross-border reproductive care)
- Embarazo y nacimientos múltiples: mellizos, trillizos, o mayor número de bebés (Multiple pregnancy and birth booklet)
- Evaluación del útero (Evaluation of the uterus)
- Transferencia electiva de un único embrión (Elective single embryo transfer)
- Síndrome de hiperestimulación ovárica-SHO (Ovarian hyperstimulation syndrome [OHSS])
- Who Needs An Egg Donor? - a patient education micro-video
- Understanding the SART Clinic Report - a patient education micro-video
- Multiple Pregnancy and Multiple Births: Understanding the Risks for Mothers and Babies - a patient education micro-video
- Infertility Treatments - a patient education video
- Assisted Hatching
- Roe Overturned Infographics
- Hawaii
- Maryland
- Louisiana
- New York
- Ohio
- Texas
- West Virginia
- Connecticut
- Massachusetts
- Montana
- New Jersey
- Medications for inducing ovulation 排卵诱导药物
- Ovarian hyperstimulation syndrome (OHSS) 卵巢过度刺激综合征
- Third-party reproduction 第三方生殖
Publications
- Updated terminology for gamete and embryo donors: directed (identified) to replace ‘‘known’’ and nonidentified to replace ‘‘anonymous’’: a committee opinion (2022)
- Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021)
- Best practices of ASRM and ESHRE: a journey through reproductive medicine (2012)
- Current recommendations for vaccines for female infertility patients: a committee opinion (2018)
- The International Glossary on Infertility and Fertility Care (2017)
- Ethics Webinar: Dilemmas in Embryo Disposition
- Consideration of the gestational carrier: an Ethics Committee opinion (2018)
- Defining embryo donation: an Ethics Committee opinion (2016)
- Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion (2019)
- Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)
- Smoking and infertility: a committee opinion (2018)
- Ethics Webinar: Access to Infertility Care
- Child-rearing ability and the provision of fertility services (2017)
- Informing offspring of their conception by gamete or embryo donation: an Ethics Committee opinion (2018)
- Posthumous retrieval and use of gametes or embryos (2018)
- Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion (2022)
- ASRM standard embryo transfer protocol template: a committee opinion (2017)
- Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion (2020)
- Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline (2018)
- Evaluation and treatment of recurrent pregnancy loss: a committee opinion (2012)
- Minimum standards for practices offering assisted reproductive technologies: a committee opinion (2021)
- Subclinical hypothyroidism in the infertile female population: a guideline (2015)
- A review of best practices of rapid-cooling vitrification for oocytes and embryos: a committee opinion (2021)
- Fertility evaluation of infertile women: a committee opinion (2021)
- Role of assisted hatching in in vitro fertilization: a guideline (2022)
- Micro-presentation: Fertility Treatment When The Prognosis Is Very Poor Or Futile
- Disclosure of medical errors involving gametes and embryos: an Ethics Committee opinion (2016)
- Oocyte or embryo donation to women of advanced reproductive age: an Ethics Commitee opinion (2016)
- Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion (2017)
- Misconduct in third-party assisted reproduction: an Ethics Committee opinion (2018)
- Micro-presentation: Fertility Preservation in Patients Undergoing Gonadotoxic Therapy or Gonadectomy
- Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion (2018)
- Correct coding for laboratory procedures during assisted reproductive technology cycles (2016)
- Evidence-based treatments for couples with unexplained infertility: a guideline (2020)
- Guidance for Providers Caring for Women and Men Of Reproductive Age with Possible Zika Virus Exposure (2019)
- Intracytoplasmic sperm injection (ICSI) for non–male factor indications: a committee opinion (2020)
- In vitro maturation: a committee opinion (2021)
- Fertility drugs and cancer: a guideline (2016)
- Performing the embryo transfer: a guideline (2017)
- Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion (2014)
- Development of an emergency plan for in vitro fertilization programs: a committee opinion (2021)
- Guidance regarding gamete and embryo donation (2021)
- Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion (2020)
- Repetitive oocyte donation: a committee opinion (2020)
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018)